The Unitaid-funded ASCENT project aims to help patients succeed in TB treatment using digital adherence technology

Tuberculosis (TB) is still the deadliest infectious disease worldwide, killing over 4.000 people every day. This is unnecessary as TB can be cured with appropriate treatment. A number of barriers however, prevent patients from recovering from this disease, including long and complicated treatment regimens that involve the daily intake of medicines over the course of 6-24 months.

By leveraging today’s smart information and (mobile) communication technologies the ASCENT project (Adherence Support Coalition to End TB) aims to support TB patients with their treatment in a modern and more effective way through the use of digital adherence technologies such as smart pill boxes, medication sleeves and video supported treatment.

By generating evidence, establishing a global market and engaging stakeholders, ASCENT aims to make future scale up possible so that these digital innovations can be available to all TB patients worldwide.

The current situation in Ukraine

The ASCENT HQ Team is closely monitoring the current situation in Ukraine, especially with regard to our projects and staff members in the region. We have regular contact with PATH, who is responsible for the implementation of the ASCENT project in Ukraine, on the safety and security of the ASCENT staff in Ukraine. They are in our thoughts and we wish them strength in this difficult situation.

?? If you have any questions on the ongoing situation in Ukraine, whether project related queries or well wishes, please send these directly to:

Kristian van Kalmthout, ASCENT project director or Kelly Schut, ASCENT grant manager

If you have any questions on external project communication, please address your questions to Lilian Polderman, ASCENT communication manager.

news & Stories


ASCENT: invest in innovative digital tools to end TB


The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits in helping people affected by TB with their treatment by using digital adherence technology such as smart pill boxes, medication sleeves and video supported treatment.

Why adherence to treatment is so important

Problem statement:

Missing doses of medication during tuberculosis treatment has serious negative effects
Patients are more likely to stop their TB treatment
Patients can develop resistance to anti TB drugs
Patients are more likely to get TB again

what is Tuberculosis?

Funding & support

Consortium partners

Funding & Support

Consortium partners

more about the ascent project